Lung Transplantation in Respiratory Failure Patients

Respiratory Failure Clinical Trial

Official title:

Extracorporeal Membrane Oxygenation Support for Bilateral Sequential Lung Transplantation in Respiratory Failure Patients.

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00854165
• Other study ID #: 200901015R
• Status: Active, not recruiting
• Phase: N/A
• First received: March 1, 2009
• Last updated: March 2, 2009
• Start date: February 2009
• Est. completion date: June 2009

Study information

• Verified date: March 2009
• Source: National Taiwan University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

Survival after cadaveric lung transplantation in recipients depended on ventilation support prior to transplantation has been reported to have relative high surgical mortality and morbidity rate. The objectives of this study were to describe the short-term outcomes of bilateral sequential lung transplantation under extracorporeal membrane oxygenation (ECMO) support in a consecutive series of patients who depended on noninvasive and invasive ventilation support preoperatively .

Description:

The one-year survival rate and postoperative pulmonary functional results will be reported in this study.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 10
• Est. completion date: June 2009
• Est. primary completion date: April 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• respiratory patients depended on ventilator supports prior to lung transplant

Exclusion Criteria:

• non-cardaveric lung transplant

Study Design

Observational Model: Case Control, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Respiratory Failure
• Respiratory Insufficiency

Locations

Country	Name	City	State
Taiwan	Department of Surgery, National Taiwan University Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	6 months and one year survival after lung transplatn.		6 months and one year posttransplant	No
Secondary	Pulmonary function results, at baseline and posttransplant 1, 3, and 6 months.		baseline, post-op 1,3, and 6 months	No